Importance of subchondral bone in the pathogenesis and management of osteoarthritis from bench to bed

Journal of Orthopaedic Translation

Volumn 2, Issue 1, 2014, Pages 16-25

  Wen, Chunyi ^a   Lu, Weijia William ^a   Chiu, Kwong Yuen ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Animal model; Articular cartilage; Osteoarthritis; Subchondral bone

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ADAMTS1 PROTEIN; ALENDRONIC ACID; CATHEPSIN K; COLLAGEN FIBRIL; COLLAGENASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOCALCIN; OSTEOPROTEGERIN; SMAD3 PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

AGING; ANTERIOR CRUCIATE LIGAMENT INJURY; BONE LESION; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DIET SUPPLEMENTATION; GENETIC REGULATION; HISTOPATHOLOGY; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOARTHRITIS; REVIEW; SUBCHONDRAL BONE PLATE; WALKING DIFFICULTY; WEIGHT GAIN;

EID: 85031868951     PISSN: 2214031X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jot.2013.11.004     Document Type: Review

References (125)

1. Zhang Y., Jordan J.M. Epidemiology of osteoarthritis. Rheum Dis Clin North Am 2008, 34:515-529.
2. Yan C.H., Chiu K.Y., Ng F.Y. Total knee arthroplasty for primary knee osteoarthritis: changing pattern over the past 10 years. Hong Kong Med J 2011, 17:20-25.
3. Woo J., Lau E., Lau C.S., Lee P., Zhang J., Kwok T., et al. Socioeconomic impact of osteoarthritis in Hong Kong: utilization of health and social services, and direct and indirect costs. Arthritis Rheum 2003, 49:526-534.
4. Woo J., Lau E., Lee P., Kwok T., Lau W.C., Chan C., et al. Impact of osteoarthritis on quality of life in a Hong Kong Chinese population. J Rheumatol 2004, 31:2433-2438.
5. Arden N.K., Leyland K.M. Osteoarthritis year 2013 in review: clinical. Osteoarthritis Cartilage 2013, 21:1409-1413.
6. Zhang Y., Jordan J.M. Epidemiology of osteoarthritis. Clin Geriatr Med 2010, 26:355-369.
7. Lories R.J., Luyten F.P. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 2011, 7:43-49.
8. Madry H., van Dijk C.N., Mueller-Gerbl M. The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc 2010, 18:419-433.
9. Murphy C.L., Murphy E., Duffy T., O'Sullivan M., Barry M. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 2013, 72:e13.
10. Jones M.D., Tran C.W., Li G., Maksymowych W.P., Zernicke R.F., Doschak M.R. Invivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and anti-inflammatory drugs as preventive treatments of osteoarthritis in the rat. Arthritis Rheum 2010, 62:2726-2735.
11. Wen C.Y., Wu C.B., Tang B., Wang T., Yan C.H., Lu W.W., et al. Collagen fibril stiffening in osteoarthritic cartilage of human beings revealed by atomic force microscopy. Osteoarthritis Cartilage 2012, 20:916-922.
12. Stolz M., Gottardi R., Raiteri R., Miot S., Martin I., Imer R., et al. Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy. Nat Nanotechnol 2009, 4:186-192.
13. Ho M.C., Lo A.C., Kurihara H., Yu A.C., Chung S.S., Chung S.K. Endothelin-1 protects astrocytes from hypoxic/ischemic injury. FASEB J 2001, 15:618-626.
14. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
15. Ryu J.H., Shin Y., Huh Y.H., Yang S., Chun C.H., Chun J.S. Hypoxia-inducible factor-2α regulates Fas-mediated chondrocyte apoptosis during osteoarthritic cartilage destruction. Cell Death Differ 2012, 19:440-450.
16. Ryu J.H., Yang S., Shin Y., Rhee J., Chun C.H., Chun J.S. Interleukin-6 plays an essential role in hypoxia-inducible factor 2α-induced experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum 2011, 63:2732-2743.
17. Yang S., Kim J., Ryu J.H., Oh H., Chun C.H., Kim B.J., et al. Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010, 16:687-693.
18. Saleh A.S., Najjar S.S., Muller D.C., Shetty V., Ferrucci L., Gelber A.C., et al. Arterial stiffness and hand osteoarthritis: a novel relationship?. Osteoarthritis Cartilage 2007, 15:357-361.
19. Echtermeyer F., Bertrand J., Dreier R., Meinecke I., Neugebauer K., Fuerst M., et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 2009, 15:1072-1076.
20. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
21. Neuhold L.A., Killar L., Zhao W., Sung M.L., Warner L., Kulik J., et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001, 107:35-44.
22. Sampson E.R., Hilton M.J., Tian Y., Chen D., Schwarz E.M., Mooney R.A., et al. Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med 2011, 3:101ra93.
23. Lin A.C., Seeto B.L., Bartoszko J.M., Khoury M.A., Whetstone H., Ho L., et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 2009, 15:1421-1425.
24. Yang X., Chen L., Xu X., Li C., Huang C., Deng C.X. TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 2001, 153:35-46.
25. Hirai T., Chagin A.S., Kobayashi T., Mackem S., Kronenberg H.M. Parathyroid hormone/parathyroid hormone-related protein receptor signaling is required for maintenance of the growth plate in postnatal life. Proc Natl Acad Sci USA 2011, 108:191-196.
26. Kobayashi T., Soegiarto D.W., Yang Y., Lanske B., Schipani E., McMahon A.P., et al. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest 2005, 115:1734-1742.
27. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
28. Blaney Davidson E.N., Remst D.F., Vitters E.L., van Beuningen H.M., Blom A.B., Goumans M.J., et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 2009, 182:7937-7945.
29. Janusz M.J., Little C.B., King L.E., Hookfin E.B., Brown K.K., Heitmeyer S.A., et al. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration. Osteoarthritis Cartilage 2004, 12:720-728.
30. van den Berg W.B., van Osch G.J., van der Kraan P.M., van Beuningen H.M. Cartilage destruction and osteophytes in instability-induced murine osteoarthritis: role of TGFβ in osteophyte formation?. Agents Actions 1993, 40:215-219.
31. Scharstuhl A., Glansbeek H.L., van Beuningen H.M., Vitters E.L., van der Kraan P.M., van den Berg W.B. Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 2002, 169:507-514.
32. Blaney Davidson E.N., Vitters E.L., van Beuningen H.M., van de Loo F.A., van den Berg W.B., van der Kraan P.M. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor β-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 2007, 56:4065-4073.
33. Scharstuhl A., Vitters E.L., van der Kraan P.M., van den Berg W.B. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor β/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 2003, 48:3442-3451.
34. Vanwanseele B., Lucchinetti E., Stussi E. The effects of immobilization on the characteristics of articular cartilage: current concepts and future directions. Osteoarthritis Cartilage 2002, 10:408-419.
35. Zhen G., Wen C., Jia X., Li Y., Crane J.L., Mears S.C., et al. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013, 19:704-712.
36. Saito T., Fukai A., Mabuchi A., Ikeda T., Yano F., Ohba S., et al. Transcriptional regulation of endochondral ossification by HIF-2α during skeletal growth and osteoarthritis development. Nat Med 2010, 16:678-686.
37. Johnson K., Zhu S., Tremblay M.S., Payette J.N., Wang J., Bouchez L.C., et al. A stem cell-based approach to cartilage repair. Science 2012, 336:717-721.
38. Kamekura S., Hoshi K., Shimoaka T., Chung U., Chikuda H., Yamada T., et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005, 13:632-641.
39. Fassler R., Schnegelsberg P.N., Dausman J., Shinya T., Muragaki Y., McCarthy M.T., et al. Mice lacking α1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci USA 1994, 91:5070-5074.
40. Blair-Levy J.M., Watts C.E., Fiorentino N.M., Dimitriadis E.K., Marini J.C., Lipsky P.E. A type I collagen defect leads to rapidly progressive osteoarthritis in a mouse model. Arthritis Rheum 2008, 58:1096-1106.
41. Wu Q., Kim K.O., Sampson E.R., Chen D., Awad H., O'Brien T., et al. Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum 2008, 58:3132-3144.
42. Yao J.Y., Wang Y., An J., Mao C.M., Hou N., Lv Y.X., et al. Mutation analysis of the Smad3 gene in human osteoarthritis. Eur J Hum Genet 2003, 11:714-717.
43. van de Laar I.M., van der Linde D., Oei E.H., Bos P.K., Bessems J.H., Bierma-Zeinstra S.M., et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 2012, 49:47-57.
44. Valdes A.M., Spector T.D., Tamm A., Kisand K., Doherty S.A., Dennison E.M., et al. Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum 2010, 62:2347-2352.
45. Suri S., Walsh D.A. Osteochondral alterations in osteoarthritis. Bone 2012, 51:204-211.
46. Hunter D.J., Gerstenfeld L., Bishop G., Davis A.D., Mason Z.D., Einhorn T.A., et al. Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther 2009, 11:R11.
47. Crema M.D., Roemer F.W., Zhu Y., Marra M.D., Niu J., Zhang Y., et al. Subchondral cyst-like lesions develop longitudinally in areas of bone marrow edema-like lesions in patients with or at risk for knee osteoarthritis: detection with MR imaging - the MOST study. Radiology 2010, 256:855-862.
48. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and blood institute Scientific statement. Circulation 2005, 112:2735-2752.
49. Link T.M., Steinbach L.S., Ghosh S., Ries M., Lu Y., Lane N., et al. Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings. Radiology 2003, 226:373-381.
50. Xu L., Hayashi D., Roemer F.W., Felson D.T., Guermazi A. Magnetic resonance imaging of subchondral bone marrow lesions in association with osteoarthritis. Semin Arthritis Rheum 2012, 42:105-118.
51. Torres L., Dunlop D.D., Peterfy C., Guermazi A., Prasad P., Hayes K.W., et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage 2006, 14:1033-1040.
52. Tanamas S., Hanna F.S., Cicuttini F.M., Wluka A.E., Berry P., Urquhart D.M. Does knee malalignment increase the risk of development and progression of knee osteoarthritis? A systematic review. Arthritis Rheum 2009, 61:459-467.
53. Yusuf E., Kortekaas M.C., Watt I., Huizinga T.W., Kloppenburg M. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Ann Rheum Dis 2011, 70:60-67.
54. Tanamas S.K., Wluka A.E., Pelletier J.P., Martel-Pelletier J., Abram F., Wang Y., et al. The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis: a longitudinal study. Arthritis Res Ther 2010, 12:R58.
55. Hunter D.J., Zhang Y., Niu J., Goggins J., Amin S., LaValley M.P., et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006, 54:1529-1535.
56. McErlain D.D., Milner J.S., Ivanov T.G., Jencikova-Celerin L., Pollmann S.I., Holdsworth D.W. Subchondral cysts create increased intra-osseous stress in early knee OA: a finite element analysis using simulated lesions. Bone 2011, 48:639-646.
57. Durr H.D., Martin H., Pellengahr C., Schlemmer M., Maier M., Jansson V. The cause of subchondral bone cysts in osteoarthrosis: a finite element analysis. Acta Orthop Scand 2004, 75:554-558.
58. Seah S., Wheaton D., Li L., Dyke J.P., Talmo C., Harvey W.F., et al. The relationship of tibial bone perfusion to pain in knee osteoarthritis. Osteoarthritis Cartilage 2012, 20:1527-1533.
59. Lee J.H., Dyke J.P., Ballon D., Ciombor D.M., Rosenwasser M.P., Aaron R.K. Subchondral fluid dynamics in a model of osteoarthritis: use of dynamic contrast-enhanced magnetic resonance imaging. Osteoarthritis Cartilage 2009, 17:1350-1355.
60. Aaron R.K., Dyke J.P., Ciombor D.M., Ballon D., Lee J., Jung E., et al. Perfusion abnormalities in subchondral bone associated with marrow edema, osteoarthritis, and avascular necrosis. Ann N Y Acad Sci 2007, 1117:124-137.
61. Findlay D.M. Vascular pathology and osteoarthritis. Rheumatology (Oxford) 2007, 46:1763-1768.
62. Conaghan P.G., Vanharanta H., Dieppe P.A. Is progressive osteoarthritis an atheromatous vascular disease?. Ann Rheum Dis 2005, 64:1539-1541.
63. Couchourel D., Aubry I., Delalandre A., Lavigne M., Martel-Pelletier J., Pelletier J.P., et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 2009, 60:1438-1450.
64. Sanchez C., Deberg M.A., Bellahcene A., Castronovo V., Msika P., Delcour J.P., et al. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum 2008, 58:442-455.
65. Sanchez C., Deberg M.A., Piccardi N., Msika P., Reginster J.Y., Henrotin Y.E. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2005, 13:988-997.
66. Sanchez C., Deberg M.A., Piccardi N., Msika P., Reginster J.Y., Henrotin Y.E. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1β and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 2005, 13:979-987.
67. Amin S., Guermazi A., Lavalley M.P., Niu J., Clancy M., Hunter D.J., et al. Complete anterior cruciate ligament tear and the risk for cartilage loss and progression of symptoms in men and women with knee osteoarthritis. Osteoarthritis Cartilage 2008, 16:897-902.
68. Hill C.L., Seo G.S., Gale D., Totterman S., Gale M.E., Felson D.T. Cruciate ligament integrity in osteoarthritis of the knee. Arthritis Rheum 2005, 52:794-799.
69. McErlain D.D., Ulici V., Darling M., Gati J.S., Pitelka V., Beier F., et al. An invivo investigation of the initiation and progression of subchondral cysts in a rodent model of secondary osteoarthritis. Arthritis Res Ther 2012, 14:R26.
70. Poole R., Blake S., Buschmann M., Goldring S., Laverty S., Lockwood S., et al. Recommendations for the use of preclinical models in the study and treatment of osteoarthritis. Osteoarthritis Cartilage 2010, 18(Suppl 3):S10-S16.
71. Ma H.L., Blanchet T.J., Peluso D., Hopkins B., Morris E.A., Glasson S.S. Osteoarthritis severity is sex dependent in a surgical mouse model. Osteoarthritis Cartilage 2007, 15:695-700.
72. Fahlgren A., Andersson B., Messner K. TGF-β1 as a prognostic factor in the process of early osteoarthrosis in the rabbit knee. Osteoarthritis Cartilage 2001, 9:195-202.
73. Tang Y., Wu X., Lei W., Pang L., Wan C., Shi Z., et al. TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009, 15:757-765.
74. Wu X., Pang L., Lei W., Lu W., Li J., Li Z., et al. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 2010, 7:571-580.
75. Lane N.E., Schnitzer T.J., Birbara C.A., Mokhtarani M., Shelton D.L., Smith M.D., et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 2010, 363:1521-1531.
76. DeGroot J., Bank R.A., Tchetverikov I., Verzijl N., TeKoppele J.M. Molecular markers for osteoarthritis: the road ahead. Curr Opin Rheumatol 2002, 14:585-589.
77. Wen C.Y., Yan C.H., Chung S.K., Chiu K.Y. Development of osteoarthritis-like changes in transgenic endothelin-1 over-expressed mice. The Thirteen International Conference on Endothelin 2013, 50. Elsevier, Tokyo, Japan. N. Emoto, T. Miyauchi (Eds.).
78. Rahman M.M., Kopec J.A., Cibere J., Goldsmith C.H., Anis A.H. The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study. BMJ Open 2013, 3:e002624.
79. Quasnichka H.L., Anderson-MacKenzie J.M., Tarlton J.F., Sims T.J., Billingham M.E., Bailey A.J. Cruciate ligament laxity and femoral intercondylar notch narrowing in early-stage knee osteoarthritis. Arthritis Rheum 2005, 52:3100-3109.
80. Muraoka T., Hagino H., Okano T., Enokida M., Teshima R. Role of subchondral bone in osteoarthritis development: a comparative study of two strains of guinea pigs with and without spontaneously occurring osteoarthritis. Arthritis Rheum 2007, 56:3366-3374.
81. Ding M., Danielsen C.C., Hvid I. Age-related three-dimensional microarchitectural adaptations of subchondral bone tissues in guinea pig primary osteoarthrosis. Calcif Tissue Int 2006, 78:113-122.
82. Anderson-MacKenzie J.M., Quasnichka H.L., Starr R.L., Lewis E.J., Billingham M.E., Bailey A.J. Fundamental subchondral bone changes in spontaneous knee osteoarthritis. Int J Biochem Cell Biol 2005, 37:224-236.
83. Bendele A.M. Animal models of osteoarthritis. J Musculoskelet Neuronal Interact 2001, 1:363-376.
84. Bendele A.M. Animal models of osteoarthritis in an era of molecular biology. J Musculoskelet Neuronal Interact 2002, 2:501-503.
85. Jimenez P.A., Glasson S.S., Trubetskoy O.V., Haimes H.B. Spontaneous osteoarthritis in Dunkin Hartley guinea pigs: histologic, radiologic, and biochemical changes. Lab Anim Sci 1997, 47:598-601.
86. Wang T., Wen C.Y., Yan C.H., Lu W.W., Chiu K.Y. Spatial and temporal changes of subchondral bone proceed to microscopic articular cartilage degeneration in guinea pigs with spontaneous osteoarthritis. Osteoarthritis Cartilage 2013, 21:574-581.
87. McIlwraith C.W., Frisbie D.D., Kawcak C.E., Fuller C.J., Hurtig M., Cruz A. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse. Osteoarthritis Cartilage 2010, 18(Suppl 3):S93-S105.
88. Little C.B., Smith M.M., Cake M.A., Read R.A., Murphy M.J., Barry F.P. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in sheep and goats. Osteoarthritis Cartilage 2010, 18(Suppl 3):S80-S92.
89. Cook J.L., Kuroki K., Visco D., Pelletier J.P., Schulz L., Lafeber F.P. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the dog. Osteoarthritis Cartilage 2010, 18(Suppl 3):S66-S79.
90. Laverty S., Girard C.A., Williams J.M., Hunziker E.B., Pritzker K.P. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthritis Cartilage 2010, 18(Suppl 3):S53-S65.
91. Kraus V.B., Huebner J.L., DeGroot J., Bendele A. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the guinea pig. Osteoarthritis Cartilage 2010, 18(Suppl 3):S35-S52.
92. Gerwin N., Bendele A.M., Glasson S., Carlson C.S. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rat. Osteoarthritis Cartilage 2010, 18(Suppl 3):S24-S34.
93. Glasson S.S., Chambers M.G. Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 2010, 18(Suppl 3):S17-S23.
94. Xie L., Lin A.S., Levenston M.E., Guldberg R.E. Quantitative assessment of articular cartilage morphology via EPIC-microCT. Osteoarthritis Cartilage 2009, 17:313-320.
95. Henriksen K., Neutzsky-Wulff A.V., Bonewald L.F., Karsdal M.A. Local communication on and within bone controls bone remodeling. Bone 2009, 44:1026-1033.
96. Xian L., Wu X., Pang L., Lou M., Rosen C.J., Qiu T., et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 2012, 18:1095-1101.
97. Park D., Spencer J.A., Koh B.I., Kobayashi T., Fujisaki J., Clemens T.L., et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 2012, 10:259-272.
98. Chiba K., Nango N., Kubota S., Okazaki N., Taguchi K., Osaki M., et al. Relationship between microstructure and degree of mineralization in subchondral bone of osteoarthritis: a synchrotron radiation microCT study. J Bone Miner Res 2012, 27:1511-1517.
99. Hilal G., Massicotte F., Martel-Pelletier J., Fernandes J.C., Pelletier J.P., Lajeunesse D. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. J Bone Miner Res 2001, 16:713-721.
100. Alexandersen P., Karsdal M.A., Qvist P., Reginster J.Y., Christiansen C. Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women. Bone 2007, 40:218-222.
101. Henrotin Y., Labasse A., Zheng S.X., Galais P., Tsouderos Y., Crielaard J.M., et al. Strontium ranelate increases cartilage matrix formation. J Bone Miner Res 2001, 16:299-308.
102. Tat S.K., Pelletier J.P., Mineau F., Caron J., Martel-Pelletier J. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts. Bone 2011, 49:559-567.
103. Nielsen R.H., Bay-Jensen A.C., Byrjalsen I., Karsdal M.A. Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover. Osteoarthritis Cartilage 2011, 19:466-473.
104. Carbone L.D., Nevitt M.C., Wildy K., Barrow K.D., Harris F., Felson D., et al. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004, 50:3516-3525.
105. Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., Destefano J., et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004, 50:1193-1206.
106. Neogi T., Nevitt M.C., Ensrud K.E., Bauer D., Felson D.T. The effect of alendronate on progression of spinal osteophytes and disc-space narrowing. Ann Rheum Dis 2008, 67:1427-1430.
107. Weinstein R.S., Roberson P.K., Manolagas S.C. Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 2009, 360:53-62.
108. Hayami T., Zhuo Y., Wesolowski G.A., Pickarski M., Duongle T. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone 2012, 50:1250-1259.
109. Kozawa E., Nishida Y., Cheng X.W., Urakawa H., Arai E., Futamura N., et al. Osteoarthritic change is delayed in a Ctsk-knockout mouse model of osteoarthritis. Arthritis Rheum 2012, 64:454-464.
110. Tat S.K., Pelletier J.P., Velasco C.R., Padrines M., Martel-Pelletier J. New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?. Keio J Med 2009, 58:29-40.
111. Arufe M.C., De la Fuente A., Fuentes I., de Toro F.J., Blanco F.J. Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes. J Cell Biochem 2010, 111:834-845.
112. + multipotential stromal cells (MSCs) in intramedullary cavities of long bones. Bone 2012, 50:510-517.
113. + multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum 2010, 62:1944-1954.
114. Grogan S.P., Miyaki S., Asahara H., D'Lima D.D., Lotz M.K. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther 2009, 11:R85.
115. Koelling S., Kruegel J., Irmer M., Path J.R., Sadowski B., Miro X., et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell 2009, 4:324-335.
116. Singh G., Miller J.D., Lee F.H., Pettitt D., Russell M.W. Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care 2002, 8:S383-S391.
117. Zhuo Q., Yang W., Chen J., Wang Y. Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol 2012, 8:729-737.
118. Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Postgrad Med J 2012, 88:240-242.
119. Yoshimura N., Muraki S., Oka H., Tanaka S., Kawaguchi H., Nakamura K., et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage 2012, 20:1217-1226.
120. Metz J.A., Morris C.D., Roberts L.A., McClung M.R., McCarron D.A. Blood pressure and calcium intake are related to bone density in adult males. Br J Nutr 1999, 81:383-388.
121. Lethbridge-Cejku M., Tobin J.D., Scott W.W., Reichle R., Roy T.A., Plato C.C., et al. Axial and hip bone mineral density and radiographic changes of osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. J Rheumatol 1996, 23:1943-1947.
122. Vestergaard P., Rejnmark L., Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int 2009, 84:103-111.
123. Schwartz A.V., Vittinghoff E., Bauer D.C., Hillier T.A., Strotmeyer E.S., Ensrud K.E., et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 2011, 305:2184-2192.
124. Hofbauer L.C., Brueck C.C., Singh S.K., Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007, 22:1317-1328.
125. Wen C.Y., Chen Y., Tang H.L., Yan C.H., Lu W.W., Chiu K.Y. Bone loss at subchondral plate in knee osteoarthritis patients with hypertension and type 2 diabetes mellitus. Osteoarthritis Cartilage 2013, 21:1716-1723.